UPDATE: Boston Scientific Posts In-Line Q4 Earnings, Issues Weak Forecast

reported in-line earnings for the fourth quarter, but the company issued a weak outlook. The Marlborough, Massachusetts-based company posted quarterly net income of $87 million, or $0.06 per share, compared to $108 million, or $0.08 per share, in the year-ago quarter. Its adjusted earnings came in at $0.22 per share. Its sales climbed 7% to $1.887 billion. However, analysts were expecting earnings of $0.22 per share on revenue of $1.90 billion. "2014 was another year of significant achievement for Boston Scientific," said Mike Mahoney, president and chief executive officer, Boston Scientific Corporation. "We strengthened our core businesses and invested in new technologies and global markets, which contributed to excellent results across our businesses and regions." For the first quarter, Boston Scientific now projects adjusted earnings of $0.19 to $0.21 per share, versus analysts' estimates of $0.22 per share. It expects sales of $1.74 billion to $1.80 billion, versus estimates of $1.828 billion. Boston Scientific projects FY15 earnings of $0.88 to $0.92 per share on revenue of $7.3 billion to $7.5 billion. Boston Scientific shares gained 0.27% to close at $14.65 yesterday.